Author

Xavier Ansolabehere

Observed names: Ansolabehere, Xavier, X Ansolabehere, X. Ansolabehere, XAVIER ANSOLABEHERE

Observed institution: IQVIA (France)

ORCID: 0009-0007-4619-265X

Observed ORCID: 0009-0007-4619-265X

OpenAlex ID: A5075022481

Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France

2018 · Philippe Devillier, Mathieu Molimard, et al. · Allergy · 68

Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis

2016 · Fredrik Nyberg, Laura Horne, et al. · Advances in Therapy · 19

PDF

Nine-Year Follow-Up of Children with Atopic Dermatitis by General Practitioners

2014 · Laurent Misery, Xavier Ansolabehere, et al. · Dermatology · 13

Penetration rates of new pharmaceutical products in Europe: A comparative study of several classes recently launched in type-2 diabetes

2021 · Claude Le Pen, Bernard Bauduceau, et al. · Annales d Endocrinologie · 9

PDF

Real-life persistence of long-acting injectable antipsychotics in schizophrenic patients: A retrospective observational study in France

2019 · Pascal Guillon, Sarah Harmand, et al. · International Journal of Clinical Pharmacology and Therapeutics · 6

Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis

2016 · Robert Morlock, Pierre Chevalier, et al. · Rheumatology and Therapy · 6

PDF

Assessing The Real-World Hospital Economic Burden Of Spinal Muscular Atrophy (SMA) In France

2017 · A Tetafort, S Couray-Targe, et al. · Value in Health · 3

Pin151 Patients Treated for Hepatitis C: an Observational Study With the French Administrative Health Care Database (snds)

2019 · S. Pol, I. Rodriguez, et al. · Value in Health · 2

PDF

Real-life cost of vitamin K antagonist treatment in patients with non-valvular atrial fibrillation in France in 2013

2017 · Jean Dallongeville, Xavier Ansolabehere, et al. · Journal of Medical Economics · 2

PDF

FRI0343 Evaluation of the Impact of Current Treatment on Serum Urate Profile, Gout Flares and Tophi in Patients with Gout in France, Germany, United Kingdom and the United States

2015 · J. Nuevo, F. Nyberg, et al. · Annals of the Rheumatic Diseases · 2

Analyse rétrospective longitudinale en vie réelle montrant l’évolution naturelle à long terme de l’asthme chez des patients allergiques aux pollens de graminées traités par comprimés d’immunothérapie sublinguale

2018 · P. Demoly, P. Devillier, et al. · Revue française d'allergologie · 1

Timing of antifibrotic therapy and prognosis in idiopathic pulmonary fibrosis: real-world evidence from the French Colibri-ILD SNDS database

2026 · Vincent Cottin, Bruno Crestani, et al. · Respiratory Research

Real-world persistence with antifibrotic treatments: a nationwide study on claims data in France (The REPEAT study)

2026 · Vincent Cottin, Marie Najean, et al. · Respiratory Research

EPH204 Real-life-Persistence to Antifibrotic Treatments in the French Population

2025 · Vincent Cottin, Marie Najean, et al. · Value in Health

Late Breaking Abstract - Determinants of Non-Persistence to Antifibrotic Therapy in Real-World Clinical Practice in the French population

2025 · Vincent Cottin, Marie Najean, et al. · European Respiratory Journal

Project Victoria: A pragmatic data model to automate RWE generation from the national French claims database

2025 · Kevin Ouazzani, Xavier Ansolabehere, et al. · Health Informatics Journal

Évolution de la prise en charge de l’hépatite C en France : étude observationnelle réalisée à partir des données du Système national des données de santé

2019 · F. Fayssoil, M. Lemaitre, et al. · Revue d Épidémiologie et de Santé Publique

Impact d’un traitement par un comprimé d’immunothérapie sublinguale aux pollens de 5 graminées sur la rhinite allergique aux pollens de graminées et l’évolution naturelle de l’asthme : analyse à long terme en vie réelle en France

2018 · P. Devillier, P. Demoly, et al. · Revue française d'allergologie

Analyse rétrospective longitudinale en vie réelle montrant l’évolution à long terme de la rhinite allergique aux pollens de graminées chez des patients traités par comprimés d’immunothérapie sublinguale

2018 · P. Demoly, P. Devillier, et al. · Revue française d'allergologie

Evaluating The Real-Life Daily-Cost of Treatment With Antiepileptic Drugs In France: A Study Based on The Combination Of French National Health Insurance Public Database, and The EMR LPD Private Database

2017 · A Troubat, C Bodaghi, et al. · Value in Health

PDF

Long-Term Impact of Grass-Pollen (GP) Sublingual Immunotherapy Tablet (SLIT) on Allergic Rhinitis (AR) and on Allergic Asthma (AA) Onset and Progression

2017 · P Devillier, M Molimard, et al. · Value in Health

PDF

Consommation des antidiabétiques oraux. Une étude comparative dans les cinq principaux pays européens

2017 · C. Le Pen, X. Ansolabehere, et al. · Médecine des Maladies Métaboliques

Costs Evolution Of Cancer Therapies In Europe From 2004 To 2014

2016 · A Tetafort, J Aubert, et al. · Value in Health

FRI0350 Evaluation of Cardiovascular and Renal Morbidity in Patients with Gout in Germany, United Kingdom, United States, and France: The International Comorbidity and Resource Utilization Study of Gout (ICARUS)

2015 · J. Nuevo, F. Nyberg, et al. · Annals of the Rheumatic Diseases

PO9 Diabète de type 2 : quels objectifs thérapeutiques selon les nouvelles recommandations de l’HAS ? Analyse de 6 680 patients suivis par des médecins généralistes

2014 · E. Larger, X. Ansolabehere, et al. · Diabetes & Metabolism

Works count: 32

Citation count: 131

H-index: 6

I10-index: 3